KITLG and melanoma: In detail, Interleukin 6 receptor alpha (IL-6RA) was overexpressed 1.4-fold (p = 0.004), Stem cell factor (SCF) 1.33-fold (p = 0.033), Vascular endothelial growth factor D (VEGF-D) 1.75-fold, Chemokine ligand 19 (CCL 19) 1.9-fold (p = 0.038), and Melanoma-derived growth regulatory protein (MIA—Melanoma inhibitory activity) 1.32-fold (p = 0.040).